Growth hormone favorably affects bone turnover and bone mineral density in patients with short bowel syndrome undergoing intestinal rehabilitation

Journal of Parenteral and Enteral Nutrition

Volumn 30, Issue 6, 2006, Pages 480-486

  Tangpricha, Vin ^a,c   Luo, Menghua ^a,c   Fernández Estívariz, Concepción ^a   Gu, Li H ^a   Bazargan, Niloofar ^a   Klapproth, Jan Michael ^a   Sitaraman, Shanthi V ^a   Galloway, John R ^b   Leader, Lorraine M ^a   Ziegler, Thomas R ^a,c,d  

^a Departments of Medicine   (United States)

^b Departments of Surgery   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; HUMAN GROWTH HORMONE; OSTEOCALCIN; PEPTIDE; VITAMIN D;

ARTICLE; BLOOD; BONE; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INTESTINE ABSORPTION; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; RADIODENSITOMETRY; RANDOMIZED CONTROLLED TRIAL; SHORT BOWEL SYNDROME; TIME; TREATMENT OUTCOME; URINE;

BONE AND BONES; BONE DENSITY; CALCIUM; COLLAGEN TYPE I; DENSITOMETRY, X-RAY; DOUBLE-BLIND METHOD; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INTESTINAL ABSORPTION; MALE; MIDDLE AGED; OSTEOCALCIN; PARENTERAL NUTRITION; PEPTIDES; SHORT BOWEL SYNDROME; TIME FACTORS; TREATMENT OUTCOME; VITAMIN D;

EID: 34147138891     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607106030006480     Document Type: Article

References (40)

1. Haderslev KV, Jeppesen PB, Sorensen HA, Mortensen PB, Staun M. Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection. Gut. 2003;52:653-658.
2. Shike M, Harrison JE, Sturtridge WC, et al. Metabolic bone disease in patients receiving long-term total parenteral nutrition. Ann Intern Med. 1980;92:343-350.
3. Verhage AH, Cheong WK, Allard JP, Jeejeebhoy KN, Harry M. Vars Research Award: increase in lumbar spine bone mineral content in patients on long-term parenteral nutrition without vitamin D supplementation. JPEN J Parenter Enteral Nutr. 1995;19:431-436.
4. Bengoa JM, Sitrin MD, Wood RJ, Rosenberg IH. Amino acid-induced hypercalciuria in patients on total parenteral nutrition. Am J Clin Nutr. 1983;38:264-269.
5. Seguy D, Vahedi K, Kapel N, Souberbielle JC, Messing B. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology. 2003;124:293-302.
6. Parekh NR, Steiger E. Criteria for the use of recombinant human growth hormone in short bowel syndrome. Nutr Clin Pract. 2005; 20:503-508.
7. Byrne TA, Wilmore DW, Iyer K, et al. Growth hormone, glu-tamine and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial. Ann Surg. 2005; 242:655-661.
8. Hansen TB, Brixen K, Vahl N, et al. Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. J Clin Endocrinol Metab. 1996;81:3352-3359.
9. Rodriguez-Arnao J, James I, Jabbar A, et al. Serum collagen cross-links as markers of bone turn-over during GH replacement therapy in growth hormone deficient adults. Clin Endocrinol (Oxf). 1988;48:455-462.
10. Baum HB, Biller BM, Finkelstein JS, et al. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. Ann Intern Med. 1986;125:883-890.
11. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004;79:362-371.
12. Byrne TA, Morrissey TB, Nattakom TV, Ziegler TR, Wilmore DW. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN J Parenter Enteral Nutr. 1995;19:296-302.
13. Byrne TA, Persinger RL, Young LS, Ziegler TR, Wilmore DW. A new treatment for patients with short-bowel syndrome: growth hormone, glutamine, and a modified diet. Ann Surg. 1995;222: 243-254.
14. Matarese LE, O'Keefe SJ, Kandil HM, Bond G, Costa G, Abu-Elmagd K. Short bowel syndrome: clinical guidelines for nutrition management. Nutr Clin Pract. 2005;20:493-502.
15. Saitta JC, Ott SM, Sherrard DJ, Walden CE, Lipkin EW. Metabolic bone disease in adults receiving long-term parenteral nutrition: longitudinal study with regional densitometry and bone biopsy. JPEN J Parenter Enteral Nutr. 1993;17:214-219.
16. Henriksen DB, Alexandersen P, Bjarnason NH, et al. Role of gastrointestinal hormones in postprandial reduction of bone resorption. J Bone Miner Res. 2003;18:2180-2189.
17. Haderslev KV, Tjellesen L, Haderslev PH, Staun M. Assessment of the longitudinal changes in bone mineral density in patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004;28:289-294.
18. Tangpricha V, Turner A, Spina C, Decastro S, Chen TC, Holick MF. Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am J Clin Nutr. 2004;80:1645-1649.
19. Advenier E, Landry C, Colomb V, et al. Aluminum contamination of parenteral nutrition and aluminum loading in children on long-term parenteral nutrition. J Pediatr Gastroenterol Nutr. 2003;36:448-453.
20. Pironi L, Zolezzi C, Ruggeri E, Paganelli F, Pizzoferrato A, Miglioli M. Bone turnover in short-term and long-term home parenteral nutrition for benign disease. Nutrition. 2000;16:272-277.
21. Fernandez-Estívariz C, Luo M, Bazargan N, et al. Effects of modified oral diet and recombinant human growth hormone on nutrient absorption and parenteral nutrition needs in adults with severe short bowel syndrome: results from a 12-week, randomized, double-blind, placebo-controlled clinical trial [abstract]. Gastroenterology. 2006;130(suppl 2):A-68.
22. de Boer H, Blok GJ, van Lingen A, et al. Consequences of child-hood-onset growth hormone deficiency for adult bone mass. J Bone Miner Res. 1994;9:1319-1326.
23. Saggese G, Baroncelli GI, Bertelloni S, Barsanti S. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency: role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab. 1996;81: 3077-3083.
24. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab. 1992;74:118-123.
25. Baroncelli GI, Bertelloni S, Ceccarelli C, Cupelli D, Saggese G. Dynamics of bone turnover in children with GH deficiency treated with GH until final height. Eur J Endocrinol. 2000;142: 549-556.
26. Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A, Johnston DG. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Clin Endocrinol (Oxf). 1994;40:383-391.
27. Beshyah SA, Kyd P, Thomas E, Fairney A, Johnston DG. The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults. Clin Endocrinol (Oxf). 1995;42:249-254.
28. Saaf M, Hilding A, Thoren M, Troell S, Hall K. Growth hormone treatment of osteoporotic postmenopausal women: a one-year placebo-controlled study. Eur J Endocrinol. 1999;140:390-399.
29. Gillberg P, Mallmin H, Petren-Mallmin M, Ljunghall S, Nilsson AG. Two years of treatment with recombinant human growth hormone increases bone mineral density in men with idiopathic osteoporosis. J Clin Endocrinol Metab. 2002;87:4900-4906.
30. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Sloot-wegMC. Growth hormone and bone. EndocrRev. 1998;19:55-79.
31. Ueland T. GH/IGF-I and bone resorption in vivo and in vitro. Eur J Endocrinol. 2005;152:327-332.
32. Yakar S, Rosen CJ, Beamer WG, et al. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest. 2002;110:771-781.
33. Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab. 1996;81:3864-3870.
34. Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab. 2002;87:2883-2891.
35. Leichtmann GA, Bengoa JM, Bolt MJ, Sitrin MD. Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in patients with both Crohn's disease and intestinal resection. Am J Clin Nutr. 1991;54:548-552.
36. Jeppesen PB, Szkudlarek J, Hoy CE, Mortensen PB. Effect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acids status in short bowel patients: a randomized, double-blind, crossover, placebo-controlled study. Scand J Gastroenterol. 2001;36:48-54.
37. Giardino R, Torricelli P, Giavaresi G, et al. Histomorphometric bone modifications induced by growth hormone treatment in a rabbit model of short bowel syndrome. Biomed Pharmacother. 2004;58:116-122.
38. Hardin DS, Ahn C, Prestidge C, Seilheimer DK, Ellis KJ. Growth hormone improves bone mineral content in children with cystic fibrosis. J Pediatr Endocrinol Metab. 2005;18:589-595.
39. Jeppesen PB, Hartmann B, Thulesen J, et al. Glucagon-Iike peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology. 2001;120: 806-815.
40. Haderslev KV, Jeppesen PB, Hartmann B, et al. Short-term administration of glucagon-like peptide-2: effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon. Scand J Gastroenterol. 2002;37:392-398.